Digestive System Diseases  >>  pamrevlumab (FG-3019)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pamrevlumab (FG-3019) / FibroGen
NCT01181245: A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Completed
1
50
US
FG-3019
FibroGen
Locally Advanced or Metastatic Pancreatic Cancer
05/14
06/14

Download Options